Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-11-05
著者
-
Schenkel F.
Clinical Pharmacology And Toxicology Geneva University Hospitals
-
VEUTHEY J.-L.
Laboratoire de Chimie Analytique et Pharmaceutique, University of Geneva
-
Veuthey J.-l.
Laboratory Of Analytical Pharmaceutical Chemistry School Of Pharmaceutical Sciences University Of Ge
-
Veuthey J.-l.
Laboratoire De Chimie Analytique Et Pharmaceutique University Of Geneva
-
RUDAZ S.
Laboratory of Pharmaceutical Analytical Chemistry, School of Pharmacy, University of Geneva
-
DAALI Y.
Clinical Pharmacology and Toxicology, Geneva University Hospitals
-
OESTREICHER M.
Clinical Pharmacology and Toxicology, Geneva University Hospitals
-
DAYER P.
Clinical Pharmacology and Toxicology, Geneva University Hospitals
-
Rudaz S.
Laboratory Of Analytical Pharmaceutical Chemistry School Of Pharmaceutical Sciences University Of Ge
-
Dayer P.
Clinical Pharmacology And Toxicology Geneva University Hospitals
-
Daali Y.
Clinical Pharmacology And Toxicology Geneva University Hospitals
-
Oestreicher M.
Clinical Pharmacology And Toxicology Geneva University Hospitals
関連論文
- Detection of human growth hormone doping in the urine : out of competition tests are necessary
- Restricted access materials and large particle supports for on-line sample preparation : an attractive approach for biological fluids analysis
- Use of large particles support for fast analysis of methadone and its primary metabolite in human plasma by liquid chromatography-mass spectrometry
- Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor
- Determination of dexamethasone in tears by capillary electrophoresis
- Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples : Application to the assessment of CYP2D6 activity in fibromyalgia patients